Rexahn Pharmaceuticals, Inc. logo

Rexahn Pharmaceuticals (REXN) stock

REXN · Rexahn Pharmaceuticals, Inc. · NASDAQ

What is the latest news on REXN stock?

NEWSago
MaxCyte Appoints Douglas Swirsky As Chief Financial Officer

MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT))))), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced Douglas J. Swirsky has been appointed as the Company's Chief Financial Officer, effective immediately. Mr. Swirsky is a seasoned financial leader with over two decades of experience in the healthcare sector, including as a public company executive at Nasdaq-listed organizations.   "We are excited to welcome Douglas to MaxCyte where he brings exceptional financial, strategic, and operational experien

All REXN news

Latest news

5 items

Rexahn Pharmaceuticals, Inc. (REXN) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for REXN in the last 30 days. The most recent was published Mar 27, 2023.

REXN FAQ

5 questions
  • Where does REXN stock trade?
    Rexahn Pharmaceuticals, Inc. (REXN) is listed on NASDAQ.
  • What sector and industry is REXN in?
    Rexahn Pharmaceuticals, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.
  • When did Rexahn Pharmaceuticals, Inc. go public?
    Rexahn Pharmaceuticals, Inc. (REXN) completed its IPO in n/a.
  • What companies are similar to REXN?
    Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare REXN side-by-side with any of them on Quantisnow.
  • How can I track REXN on Quantisnow?
    Quantisnow aggregates Rexahn Pharmaceuticals, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow REXN to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change